Current Research and Development in the Field of Magnetic Resonance Contrast Media
Author:
- 7 July 2025
- journal article
- editorial
- Published by Wolters Kluwer Health in Investigative Radiology
- Vol. 60 (11) , 709-710
Abstract
The next-generation, high relaxivity, gadolinium-based contrast agents (GBCAs) are discussed, together with new studies of safety, improvements in MR technique, and the ongoing development of additional agents. It is likely that the next generation agents, gadopiclenol and gadoquatrane, will largely replace the current standards, the macrocyclic gadolinium chelates, despite the excellent safety profile and very high stability of the latter. In the Group of Seven (G7) nations, which includes Canada, France, Germany, Italy, Japan, the United Kingdom and the United States, use of the linear gadolinium chelates has largely ceased, due to concerns regarding their relative instability as compared to the macrocyclic agents and the deposition of gadolinium that occurs in many tissues, including brain and bone, following their injection. Manganese-based compounds are once again being investigated, a field largely untouched since the initial development of clinical MR contrast media in the 1980s. Their potential impact on clinical imaging is, however, unclear. New information continues to emerge regarding differences in stability of the gadolinium-based agents. Artificial intelligence and deep learning techniques are maturing and are discussed briefly, given their potential and recent clinical application involving MR contrast media.Keywords
This publication has 25 references indexed in Scilit:
- Gadoxetic Acid–Enhanced Liver MRIInvestigative Radiology, 2023
- Artificial Intelligence to Reduce or Eliminate the Need for Gadolinium-Based Contrast Agents in Brain and Cardiac MRIInvestigative Radiology, 2023
- Artificial ContrastInvestigative Radiology, 2023
- Reduction of Gadolinium-Based Contrast Agents in MRI Using Convolutional Neural Networks and Different Input ProtocolsInvestigative Radiology, 2023
- Contrast Agent Dose Reduction in MRI Utilizing a Generative Adversarial Network in an Exploratory Animal StudyInvestigative Radiology, 2023
- Efficacy and Safety of Gadopiclenol for Contrast-Enhanced MRI of the Central Nervous SystemInvestigative Radiology, 2022
- Skin Thickening of the Scalp and High Signal Intensity of Dentate Nucleus in Multiple SclerosisInvestigative Radiology, 2022
- Deep Learning-Based Automatic Detection and Grading of Motion-Related Artifacts on Gadoxetic Acid-Enhanced Liver MRIInvestigative Radiology, 2022
- Multiarterial Phase Acquisition in Gadoxetic Acid–Enhanced Liver MRI for the Detection of Hypervascular Hepatocellular Carcinoma in High-Risk PatientsInvestigative Radiology, 2022
- Preclinical Profile of GadoquatraneInvestigative Radiology, 2022